The effect of bullying victimization trajectory on internet gaming disorder and the mediating role of impaired resilience: a three-wave cohort study among Chinese adolescents

欺凌受害轨迹对网络游戏障碍的影响及心理韧性受损的中介作用:一项针对中国青少年的三波队列研究

阅读:2

Abstract

BACKGROUND: While bullying victimization is a known risk factor for Internet Gaming Disorder (IGD), the differential impact of distinct longitudinal victimization patterns and the underlying psychological mechanisms are poorly understood. This study aimed to identify bullying victimization trajectories and test a mediational model linking them to IGD via impaired resilience. METHODS: A three-wave longitudinal study was conducted with an initial cohort of 20,137 Chinese adolescents. Peer victimization (Multidimensional Peer-Victimization Scale), IGD (Internet Gaming Disorder Scale - Short Form), and resilience (Connor–Davidson Resilience Scale) were assessed via standard questionnaires. Growth Mixture Modeling was used to identify bullying trajectories, and a bootstrapped mediation analysis tested the hypothesized model while controlling for baseline covariates. RESULTS: Four distinct trajectories were identified: low-risk (77.8%), chronic (9.1%), remitting (9.9%), and escalating (3.2%). Compared to the low-stable group, the chronic and escalating trajectories were associated with a significantly higher risk of IGD at T3 (adjusted odds ratio [AOR] = 4.23 and AOR = 10.56, respectively; all p < 0.001). The mediating effect of resilience was significant for the chronic (0.92; 95% confidence interval [95%CI], [0.82, 1.01]) and escalating (1.24; 95% CI, [1.08, 1.41]) groups but not remitting groups. CONCLUSION: Chronic and escalating peer victimization are significant risk factors for adolescent IGD, partly by impaired resilience. A remitting pattern does not confer the same risk. Findings underscore the need for longitudinal monitoring of victimization and the implementation of resilience-building interventions as a key strategy for preventing IGD in at-risk youth. CLINICAL TRIAL NUMBER: This is not a clinical trial. Therefore, the clinical trial number was not applicable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-025-07641-2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。